Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0A0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,294
Award facts
- Contract value 100% obligated
- $60,293.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $60,293.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This non-set-aside contract represents a single delivery order with an ultimate completion date of January 15, 2026, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this a specialized pharmaceutical supply for federal military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026 that serves as a global prime vendor vehicle for military healthcare programs. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor. The award reflects AmerisourceBergen's established role in supplying specialty medications and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitive, full and open procurement.
Quick answers
Who was awarded contract SPE2DR26FN0A0?
SPE2DR26FN0A0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FN0A0 worth?
The government has obligated $60,294 on SPE2DR26FN0A0.
Is contract SPE2DR26FN0A0 an order under another contract?
Yes. SPE2DR26FN0A0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0A0 competed?
The extent of competition for SPE2DR26FN0A0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award